Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant.

Kawaguchi M, Sakurada Y, Tokumasu K, Otsuka Y, Nakano Y, Matsuda Y, Honda H, Omura D, Matsuki N, Furukawa M, Higashikage A, Otsuka F

Open source

DOI: 10.3389/bjbs.2026.16255
Published: 2026
Container: British journal of biomedical science
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/bjbs.2026.16255,
  title = {Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant.},
  author = {Kawaguchi M and Sakurada Y and Tokumasu K and Otsuka Y and Nakano Y and Matsuda Y and Honda H and Omura D and Matsuki N and Furukawa M and Higashikage A and Otsuka F},
  year = {2026},
  journal = {British journal of biomedical science},
  doi = {10.3389/bjbs.2026.16255},
  url = {https://doi.org/10.3389/bjbs.2026.16255}
}

RIS

TY  - JOUR
TI  - Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant.
AU  - Kawaguchi M
AU  - Sakurada Y
AU  - Tokumasu K
AU  - Otsuka Y
AU  - Nakano Y
AU  - Matsuda Y
AU  - Honda H
AU  - Omura D
AU  - Matsuki N
AU  - Furukawa M
AU  - Higashikage A
AU  - Otsuka F
PY  - 2026
JO  - British journal of biomedical science
DO  - 10.3389/bjbs.2026.16255
UR  - https://doi.org/10.3389/bjbs.2026.16255
ER  -

APA

M, K., Y, S., K, T., Y, O., Y, N., Y, M., H, H., D, O., N, M., M, F., A, H., & F, O. (2026). Clinical Utility of SARS-CoV-2 Antibody Titers in the Management of Patients With Long COVID Infected With the Omicron Variant.. British journal of biomedical science. https://doi.org/10.3389/bjbs.2026.16255

Source records

pubmed · retrieved 2026-11-10T15:50:02.046Z